|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 27/10 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 27/10 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Stock exchange
Nasdaq Stockholm- kr
-
0
kr
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| IRLAB A | 2.080SEK | -0.48% | 13.42L kr | ||
Deutsche Boerse AG
| 6IRA | 0.1866EUR | -0.85% | 0 € | |
|
OTC Markets
| IRLAF | -USD | -.--% | 0 $ |
Basic data
Market Cap (SEK)
30,90,61,485
Market Cap (USD)
3,16,37,388
Net sales (SEK)
5,74,62,000
Net sales (USD)
58,82,155
Free-Float
83.4%
Free-Float capitalization (SEK)
14,72,22,973
Free-Float capitalization (USD)
1,50,70,627
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 3.16Cr | |
| -0.46% | +10.80% | +63.52% | +154.48% | 1,26300Cr | |
| -0.97% | +2.56% | +43.25% | +81.96% | 66TCr | |
| -2.05% | +1.12% | +32.47% | +102.74% | 52TCr | |
| -1.54% | +1.61% | +53.42% | +67.10% | 39TCr | |
| -0.78% | +2.13% | +72.55% | +44.25% | 37TCr | |
| -1.69% | +2.75% | +32.49% | +54.35% | 31TCr | |
| -0.72% | +8.08% | +11.15% | +34.09% | 29TCr | |
| -0.12% | +5.96% | +55.97% | +78.44% | 25TCr | |
| -0.21% | +9.16% | +42.19% | +112.41% | 21TCr | |
| Average | -0.67% | +5.90% | +45.22% | +81.09% | 42.62TCr | |
| Weighted average by Cap. | -0.65% | +6.60% | +49.15% | +97.42% |
Historical Quotes: IRLAB Therapeutics AB
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IRLAB A Stock
- Stock
- Quotes IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
